What’s New

Article

Mar 19, 2024

Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024

Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide, providing unparalleled oppo…

News

Jan 8, 2024

Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer

London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective January 2024. Th…

News

Mar 20, 2023

Celebrating our Women: Part Two

Continuing with our celebration during Women’s History Month and for International Women’s day, we are proud to profile two more of the incredible women that work at Alimentiv. Today, we a…

News

Mar 17, 2023

Celebrating our Alimentiv Women

On International Women’s Day 2023, in keeping with this year’s theme of “Embrace Equity”, Alimentiv continues to celebrate the achievements of women, their courage and determination to take ac…

Publication

Feb 8, 2023

Patients With Crohn’s Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review

Christopher Ma, Eileen Crowley, Vipul Jairath.

News

Nov 3, 2022

Alimentiv, Summit Clinical Research Announce Collaboration to drive Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

London, Ontario, Canada, November 3, 2022, Alimentiv Inc. (“Alimentiv”) and Summit Clinical Research, LLC (“Summit”) today announced a strategic alliance to drive Non-Alcoholic Steatohepatitis…

News

Oct 5, 2022

Alimentiv, Satisfai Health, and Virgo Announce Partnership to use AI-driven technology to Enhance Clinical Trials in IBD and other GI Diseases

The partnership enables advanced AI-fueled HD video capture, decision support, and clinical research tools for Alimentiv’s global clinical trial investigator site network. London, Ontario, Canada, 5…

Publication

Oct 4, 2022

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease

Brian Feagan, Christopher Ma, Claire E Parker, Geert D’Haens, Niels Vande Casteele, Stefanie C McFarlane, Vipul Jairath.